ARCH Venture Management, LLC Diversified Active

CIK: 0001274403 · Show all filings

Period: Q4 2018 (Next →)

Filing Date: May 17, 2019

Total Value ($000): $100,029

Holdings (6)

— RUBIUS THERAPEUTICS INC 42.1%

Value ($000) $42,103 Shares 2,618,351 Est. Cost $16.08 Unrealized —

FATE FATE THERAPEUTICS INC 26.6%

Value ($000) $26,599 Shares 2,073,190 Est. Cost $13.94 Unrealized 0.0%

KURA KURA ONCOLOGY INC 26.1%

Value ($000) $26,063 Shares 1,856,307 Est. Cost $13.25 Unrealized 0.0%

— CHIASMA INC 3.7%

Value ($000) $3,722 Shares 1,196,776 Est. Cost $3.11 Unrealized —

— BELLEROPHON THERAPEUTICS, INC 0.8%

Value ($000) $774 Shares 965,660 Est. Cost $0.80 Unrealized —

— ACHAOGEN INC 0.8%

Value ($000) $768 Shares 624,544 Est. Cost $1.23 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	RUBIUS THERAPEUTICS INC	2,618,351	$42,103	42.1%	$16.08	—	—	78116T103
FATE	FATE THERAPEUTICS INC	2,073,190	$26,599	26.6%	$13.94	0.0%	—	31189P102
KURA	KURA ONCOLOGY INC	1,856,307	$26,063	26.1%	$13.25	0.0%	—	50127T109
—	CHIASMA INC	1,196,776	$3,722	3.7%	$3.11	—	—	16706W102
—	BELLEROPHON THERAPEUTICS, INC	965,660	$774	0.8%	$0.80	—	—	078771102
—	ACHAOGEN INC	624,544	$768	0.8%	$1.23	—	—	004449104